Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

IBEX Technologies Inc V.IBT

IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The Company operates in one industry segment: the production and sale of diagnostic products.


TSXV:IBT - Post by User

Post by guarantor1on Dec 19, 2021 3:18pm
162 Views
Post# 34245052

Potential Market for IBEX's vegetal Diamine Oxidase

Potential Market for IBEX's vegetal Diamine OxidaseFrom this Feb's Paul Baehr interview -  https://www.youtube.com/watch?v=CnEck4TM_Ec&t=1454s

at 22:30;  discussing Diamine Oxidase

a synopsis :

he estimates the US and European Market currently at $10M
and he thinks Ibex will get 1/3 very quickly , because their DAO is botanical.
so  he is guessing $3-5M @ annum
He also stated that Ibex DAO is in the Development Phase  -  things are going well, but it will take a couple of years to get it commercialized

Paul has mentioned elsewhere, that  potential DAO sales is not a huge number
But it is very significant to Ibex, given that it will constitute a large percentage of sales
(I think when he mentioned the above, current overall sales were running at around $5M)

G
<< Previous
Bullboard Posts
Next >>